Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 75.5 +1.5 (+2.03%) Sep 11
At Loss
P/B:
8.36
Market Cap:
€ 6.88B ($ 7.96B)
Enterprise V:
€ 6.02B ($ 6.96B)
Volume:
0
Avg Vol (2M):
125.00
Trade In:

Spyre Therapeutics Inc Valuation Measures